Search
Research
Mesothelioma in australia: A reviewA multidisciplinary approach to caring for patients with malignant mesothelioma and their carers is vital.
Research
Record linkage study of the pathogen-specific burden of respiratory viruses in childrenReliance on hospital discharge diagnosis codes alone will likely underestimate the burden of respiratory viruses
Research
Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescentsWe examined the association of maternal factors and infant nutrition, with the subsequent diagnosis of NAFLD in adolescents
Research
Reproducibility of the plasma glucose response to moderate-intensity exercise in adolescents with Type 1 diabetesThe plasma glucose response to moderate-intensity exercise can be reproducible in adolescents with Type 1 diabetes
Research
Trends in exposure to respirable crystalline silica (1986-2014) in Australian miningWe described trends in RCS exposure in WA miners over the past 30 years.
Research
Sustained participation in annual continuous quality improvement activities improves quality of care for Aboriginal and Torres Strait Islander childrenTo determine whether participation in the continuous quality improvement (CQI) Audit and Best Practice for Chronic Disease programme improved care and outcomes for Indigenous children
Research
Risk factors for malignant mesothelioma in people with no known exposure to asbestosThis study aimed to identify sources whereby people in Western Australia (WA) may be unknowingly exposed to asbestos or to other exposures which may cause MM.
Research
Are low sun exposure and/or Vitamin D risk factors for type 1 diabetesEvidence supports that higher sun exposure and/or vitamin D sufficiency in pregnancy, or supplementation in early life, decreases type 1 diabetes risk
Research
Characterizing the risk of respiratory syncytial virus in infants with older siblings: a population-based birth cohort studyOur results lend support to a vaccination strategy which includes family members in order to provide maximum protection for newborn babies.
Research
Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsinIdentified romidepsin as a promising therapeutic for mixed lineage leukemia (MLL)-rearranged infant acute lymphoblastic leukemia